Condition: Spinal Tumor · Sponsor: Peking University Third Hospital
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.
This description comes directly from the study's public registry record.
Hongqing Zhuang, Doctor · 13051776232 · hongqingzhuang@163.com
Yuxia Wang · 15001292991 · lily31415926@126.com
Always discuss trial participation with your own doctor first.
| Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist. | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06587022